The upcoming earnings report for AZTA is scheduled for Tuesday, May 5th, with a consensus estimate EPS of $0.1.
Azenta, Inc. (AZTA) is currently priced at $23.75, experiencing a price decrease of $1.4 (-5.57%) from the previous close. The trading volume is $172,505, which is 17.88% above the average.
The latest quarterly earnings for AZTA were reported on Tuesday, February 3rd, with a consensus estimate EPS of $0.11. The company's performance indicates a net income of -$15.43 million.
AZTA shows a positive net change in cash of $55.30 million, with operating cash flow at $20.85 million. The company has no common stock issued or repurchased.
With a revenue of $148.64 million and a gross profit of $63.71 million, AZTA reported an operating income of -$4.88 million. The diluted earnings per share (EPS) stands at -34 cents.
Key ratios for AZTA include a gross profit margin of 42.86%, a return on assets of -0.74, and a debt-to-equity ratio of 6.35.
AZTA shows total assets of $2 billion, with cash and cash equivalents amounting to $339 million and total investments at $228.94 million.
This financial snapshot of AZTA indicates a mixed performance with upcoming earnings on the horizon.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.